These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 34431629)

  • 1. [Not Available].
    Scheen AJ
    Rev Med Suisse; 2021 Aug; 17(747):1383-1384. PubMed ID: 34431629
    [No Abstract]   [Full Text] [Related]  

  • 2. [COVID-19 and Diabetes Mellitus: The Impact of Two Pandemics].
    Oliveira P; Louro J; Gil P; Andrade L
    Acta Med Port; 2022 Dec; 35(12):925-926. PubMed ID: 36469954
    [No Abstract]   [Full Text] [Related]  

  • 3. The COVID-19 Pandemic Revealed the Importance and Shortcomings of Technologies for Diabetes Support.
    Årsand E
    J Diabetes Sci Technol; 2020 Jul; 14(4):712-713. PubMed ID: 32460550
    [No Abstract]   [Full Text] [Related]  

  • 4. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
    Ceriello A; Schnell O
    J Diabetes Sci Technol; 2020 Jul; 14(4):723-724. PubMed ID: 32475168
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes mellitus and COVID-19: A review and management guidance for South Africa.
    Coetzee A; Taljaard JJ; Hugo SS; Conradie M; Conradie-Smit M; Dave JA
    S Afr Med J; 2020 Jun; 110(8):761-766. PubMed ID: 32880304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).
    Rhee SY
    Diabetes Metab J; 2021 Jul; 45(4):619-620. PubMed ID: 34352992
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).
    Schernthaner G
    Diabetes Metab J; 2021 Jul; 45(4):615-616. PubMed ID: 34352990
    [No Abstract]   [Full Text] [Related]  

  • 9. New-onset diabetes in "long COVID".
    Sathish T; Anton MC; Sivakumar T
    J Diabetes; 2021 Aug; 13(8):693-694. PubMed ID: 33893710
    [No Abstract]   [Full Text] [Related]  

  • 10. Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?
    Lui DTW; Tan KCB
    J Diabetes Investig; 2021 Apr; 12(4):479-481. PubMed ID: 33331120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?
    Schernthaner G
    Lancet Diabetes Endocrinol; 2021 May; 9(5):251-252. PubMed ID: 33798462
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations.
    Patoulias D; Katsimardou A; Papadopoulos C; Doumas M
    Acta Diabetol; 2021 Jan; 58(1):125-126. PubMed ID: 32816107
    [No Abstract]   [Full Text] [Related]  

  • 13. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and COVID-19; a Review of Possible Mechanisms.
    Moradi-Marjaneh R; Asgharzadeh F; Khordad E; Marjaneh MM
    Curr Pharm Des; 2021; 27(21):2522-2527. PubMed ID: 33655850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes and COVID-19 infection].
    Kosinski C; Zanchi A; Wojtusciszyn A
    Rev Med Suisse; 2020 May; 16(692):939-943. PubMed ID: 32374541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and diabetes: No time to drag our feet during an untimely pandemic.
    Kyrou I; Robbins T; Randeva HS
    J Diabetes Complications; 2020 Sep; 34(9):107621. PubMed ID: 33051004
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
    D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
    Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2].
    Arutiunov GP; Tarlovskaia EI; Koziolova NA; Boldina MV; Batiushin MM; Ametov AS; Arutiunov AG; Belevskii AS; Galstian GR; Grigor'eva NI; Dzhunusbekova GA; Esaian AM; Mal'chikova SV; Mit'kovskaia NP; Mkrtumian AM; Orlova IA; Petrova MM; Rebrov AP; Ruzanov DI; Salukhov VV; Sisakian AS; Skibitskii VV; Sugraliev AB; Fomin IV; Khalimov IS; Chesnikova AI; Shaposhnik II; Shestakova MV
    Ter Arkh; 2020 Oct; 92(9):108-124. PubMed ID: 33346439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
    Alcocer-Gamba MA; Gutiérrez-Fajardo P; Sosa-Caballero A; Cabrera-Rayo A; Faradji-Hazan RN; Padilla-Padilla FG; Garnica-Cuellar JC; Hernández-Arispe LM; Reyes-Cianeros FA; León-Suárez A; de-Jesús-Rivera J; Mancillas-Adame L; Gaxiola-Macias M; Márquez-Rodríguez E; Miranda-Malpica E; Sanchez-Pedraza V; Lara-Martínez DS; Segovia-Palomo A; Nava-Hernández A; Rivera-Reyes R
    Arch Cardiol Mex; 2020; 90(Supl):77-83. PubMed ID: 32523151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Lippi G; Sanchis-Gomar F; Henry BM
    J Diabetes; 2021 Feb; 13(2):179-180. PubMed ID: 33128349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.